Prudential Financial’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-133,729
| Closed | -$7.02M | – | 2544 |
|
|
2020
Q3 | $7.02M | Sell |
133,729
-41,420
| -24% | -$1.71M | 0.01% | 809 |
|
|
2020
Q2 | $5.83M | Sell |
175,149
-36,826
| -17% | -$1.17M | 0.01% | 904 |
|
|
2020
Q1 | $5.76M | Buy |
211,975
+35,005
| +20% | +$975K | 0.01% | 859 |
|
|
2019
Q4 | $3.49M | Buy |
176,970
+21,025
| +13% | +$336K | 0.01% | 1314 |
|
|
2019
Q3 | $2.02M | Sell |
155,945
-867
| -0.6% | -$10.5K | ﹤0.01% | 1577 |
|
|
2019
Q2 | $1.95M | Buy |
156,812
+490
| +0.3% | +$6.51K | ﹤0.01% | 1616 |
|
|
2019
Q1 | $2.27M | Buy |
156,322
+3,530
| +2% | +$45.1K | ﹤0.01% | 1551 |
|
|
2018
Q4 | $1.69M | Buy |
152,792
+23,200
| +18% | +$323K | ﹤0.01% | 1602 |
|
|
2018
Q3 | $3.41M | Buy |
129,592
+210
| +0.2% | +$5.68K | 0.01% | 1362 |
|
|
2018
Q2 | $2.65M | Sell |
129,382
-24,310
| -16% | -$522K | ﹤0.01% | 1506 |
|
|
2018
Q1 | $2.79M | Buy |
153,692
+27,170
| +21% | +$453K | ﹤0.01% | 1432 |
|
|
2017
Q4 | $1.76M | Sell |
126,522
-4,446
| -3% | -$60.1K | ﹤0.01% | 1640 |
|
|
2017
Q3 | $2.42M | Buy |
130,968
+12,900
| +11% | +$216K | ﹤0.01% | 1492 |
|
|
2017
Q2 | $2M | Buy |
118,068
+8,876
| +8% | +$135K | ﹤0.01% | 1563 |
|
|
2017
Q1 | $1.46M | Buy |
109,192
+1,060
| +1% | +$16.6K | ﹤0.01% | 1708 |
|
|
2016
Q4 | $1.63M | Sell |
108,132
-1,260
| -1% | -$16.6K | ﹤0.01% | 1643 |
|
|
2016
Q3 | $1.28M | Sell |
109,392
-41,150
| -27% | -$484K | ﹤0.01% | 1709 |
|
|
2016
Q2 | $1.63M | Buy |
150,542
+3,480
| +2% | +$35.9K | ﹤0.01% | 1653 |
|
|
2016
Q1 | $1.36M | Buy |
147,062
+2,700
| +2% | +$29.1K | ﹤0.01% | 1715 |
|
|
2015
Q4 | $2.14M | Buy |
144,362
+2,600
| +2% | +$43.5K | ﹤0.01% | 1476 |
|
|
2015
Q3 | $2.33M | Buy |
141,762
+8,000
| +6% | +$164K | ﹤0.01% | 1385 |
|
|
2015
Q2 | $3.05M | Buy |
133,762
+27,700
| +26% | +$552K | 0.01% | 1350 |
|
|
2015
Q1 | $1.61M | Buy |
106,062
+4,200
| +4% | +$54.6K | ﹤0.01% | 1681 |
|
|
2014
Q4 | $1.23M | Buy |
101,862
+3,500
| +4% | +$40K | ﹤0.01% | 1667 |
|
|
2014
Q3 | $1.11M | Sell |
98,362
-12,734
| -11% | -$145K | ﹤0.01% | 1683 |
|
|
2014
Q2 | $1.34M | Buy |
111,096
+5,649
| +5% | +$66.7K | ﹤0.01% | 1713 |
|
|
2014
Q1 | $1.23M | Buy |
105,447
+700
| +0.7% | +$11.9K | ﹤0.01% | 1683 |
|
|
2013
Q4 | $1.85M | Sell |
104,747
-600
| -0.6% | -$10.1K | ﹤0.01% | 1495 |
|
|
2013
Q3 | $1.52M | Sell |
105,347
-30,400
| -22% | -$465K | ﹤0.01% | 1558 |
|
|
2013
Q2 | $2.04M | Buy |
+135,747
| New | +$1.79M | ﹤0.01% | 1345 |
|
Prudential Financial's MNTA Position: Q4 2020 in Review
Prudential Financial sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 133,729 shares — an estimated $7.02M sold.
Prudential Financial first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $7.02M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Prudential Financial reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Prudential Financial sold 133,729 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $7.02M.
- Prudential Financial first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Prudential Financial's Momenta Pharmaceuticals, Inc. position peaked at $7.02M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Prudential Financial's 13F filing for Q4 2020, filed 16 Feb 2021.